Showing 1 - 3 results of 3 for search 'John P H Wilding', query time: 0.02s Refine Results
  1. 1
    1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes.

    1,25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFκB and MAPK signalling and chemokine release in human adipocytes. by Cherlyn Ding, John P H Wilding, Chen Bing

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection

    The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection by Emily Brown, John P. H. Wilding, Uazman Alam, Thomas M. Barber, Janaka Karalliedde, Daniel J. Cuthbertson

    Published 2021-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes

    Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes by James Harris, Paula R Williamson, John P H Wilding, Nicola L Harman, Jennifer Logue, Leigh Perreault, Dave Curry, R John Pemberton, Gareth Thompson, Sean Tunis, Serena Battaglia, Florence Bietrix, Jacques Demotes-Mainard, Valerie Gailus-Durner, Silvio Garattini, Tim Moser, Cecilia A C Prinsen, Michael Raess, Adrian Sanz-Moreno, Caroline B Terwee

    Published 2019-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: